David R Elmaleh

This inventor holds 93 USPTO granted patents and 44 published patent applications, plus 11 CIPO patents and 11 EPO patents, primarily in Cromolyn Derivatives (CPC class A61K31-352). Top assignees: The General Hospital Corporation, Aztherapies, Inc., Seroton, Inc.. Active years: 1985-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David R Elmaleh. Retrieved from https://idiyas.com/inventor/david-r-elmaleh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 93 (Patent Applications = 44)

% Patents Active = 63.4

CIPO Patents = 11 (Patent Applications = 13)

EPO Patents = 11 (Patent Applications = 31)

Average Co-Inventor Count = 1.6

ph-index = 17

Forward Citations = 686(Granted Patents)

Forward Citations (Not Self Cited) = 315(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Newton Center, MA (US) (1985)
Brookline, MA (US) (1993)
Boston, MA (US) (1998 - 2014)
Newtown, MA (US) (2018)
Newton, MA (US) (1996 - 2023)

Company Filing History:

60 out of 3,076

The General Hospital Corporation

Northeastern University

Children's Medical Center Corporation

patents

10. 1 out of 8

Intramedical Imaging, LLC

patents

11. 1 out of 41

Molecular Insight Pharmaceuticals, Inc.

patents

12. 1 out of 7

The General Hosptial Corporation

Zebra Pharmaceuticals

patent

15. 24 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2026

Loading Chart...

Areas of Expertise:

Cromolyn Derivatives

Drug Delivery

Alzheimer's Disease

Neuro-Inflammation

Controlled Release

Dry-Powder Inhalation

Combination Therapies

Catalytic Radiofluorination

Biotin Complexes

Macrophages

Imaging Methods

Cardiovascular Imaging

93 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612391 - Cromolyn derivatives and uses thereof (2026-04-28),

2. 12605471 - Cromolyn derivatives and related methods of imaging and treatment (2026-04-21),

3. 12458622 - Methods of treatment of coronavirus-induced inflammation conditions (2025-11-04),

4. 12383528 - Cromolyn esters and uses thereof (2025-08-12),

5. 11801316 - Cromolyn derivatives and related methods of imaging and treatment (2023-10-31),

6. 11679243 - Non-digestible, controlled release system for soluble drug delivery (2023-06-20),

7. 11679095 - Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases (2023-06-20),

8. 11666669 - Cromolyn derivatives and related methods of imaging and treatment (2023-06-06),

9. 11666664 - Self assembling molecules for targeted drug delivery (2023-06-06),

10. 11491288 - Dispenser for dry-powder inhalation devices (2022-11-08),

11. 11291648 - Powdered formulations of cromolyn sodium and alpha-lactose (2022-04-05),

12. 11110097 - Combination therapies for the treatment of alzheimer's disease and related disorders (2021-09-07),

13. 11013686 - Cromolyn compositions and methods thereof (2021-05-25),

14. 10857247 - Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders (2020-12-08),

15. 10695449 - Catalytic radiofluorination (2020-06-30),

Title: Unveiling the Innovations of David R Elmaleh

Introduction:

David R Elmaleh, a distinguished inventor based in Newton, MA (US), is a trailblazer in the field of medical imaging and drug delivery. With an impressive portfolio of 89 patents, his groundbreaking work has left a lasting impact on the healthcare industry.

Latest Patents:

Among his latest patents, one notable invention is the development of Cromolyn derivatives for imaging atherosclerotic plaques and treating diseases like atherosclerosis and Alzheimer's. These novel analogs have a unique formula aimed at revolutionizing diagnostic imaging processes. Another significant invention is the non-digestible, controlled release system for soluble drug delivery, ensuring safe and effective dispensing of drugs post-capsule ingestion.

Career Highlights:

Throughout his career, David R Elmaleh has been associated with esteemed organizations such as The General Hospital Corporation, where his innovative spirit has flourished. His relentless pursuit of excellence has led to numerous breakthroughs in the medical field, making him a highly respected figure in the industry.

Collaborations:

David R Elmaleh has collaborated with top minds in the field, including his accomplished coworkers Alan J Fischman and Timothy M Shoup. Together, they have synergized their expertise to bring forth cutting-edge solutions that push the boundaries of innovation.

Conclusion:

In conclusion, David R Elmaleh stands as a beacon of innovation, with a remarkable track record of patents that underscore his commitment to advancing healthcare technologies. His inventive spirit and collaborative efforts continue to inspire new generations of inventors to push the boundaries of what is possible in the realm of medical research and development.

Profile summary based on public USPTO records.